Dr. Michael Beyer, Dipl.-Volkswirt

Michael primarily advises German and international banks and financial institutions as well as private equity investors and corporations on complex national and cross-border financing transactions. His expertise includes in particular corporate finance, acquisition finance and restructurings. Michael also advises on other forms of credit financing, such as export financing.

Show full CV Hide full CV

Career

Since 2020	Salary Partner, Taylor Wessing
2017 - 2020	Associate, Taylor Wessing, Frankfurt
2014 – 2016	Associate, an international law firm

Education

2014	Admitted as a lawyer
2013	Second state examination, Düsseldorf
2012	Graduation, Dr. jur, Freiburg i. Brsg.

2010	First state examination
2008	Studies of economics, diploma
2003	Qualified bank clerk

More Less

Additional languages

English

Expertise

Services and Groups Banking & finance

Sectors Financial institutions Real estate

Experience

Successful financing and add on acquisitions for Oberberg Group

Oberberg Group on the successful refinancing of its existing credit lines. The new financing also served several add-on acquisitions. This included the internationally renowned private clinic Jägerwinkel am Tegernsee, which is expanding the treatment spectrum of the Group with its range of integrative holistic psychosomatics with a focus on interdisciplinary pain therapy. In addition, Panorama Fachklinik, an acute hospital for psychosomatics, and Privatklinik Hubertus im Allgäu, a specialist hospital for psychosomatics, psychotherapy and naturopathy, were acquired.

NORD Holding on the acquisition of Zentrum Gesundheit Group

NORD Holding, a leading private equity house, on the acquisition of the majority interest in Zentrum Gesundheit Group, a leading German group of ophthalmic surgery and diagnostic centres, from Waterland Private Equity. NORD Holding, together with the management and medical team, acquired a stake as a new partner and majority shareholder. In this deal the Taylor Wessing team again demonstrated its interdisciplinary expertise in the areas of healthcare M&A, regulatory and acquisition financing.